XML 29 R23.htm IDEA: XBRL DOCUMENT
v3.25.1

Stock-Based Compensation (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract] |
Schedule of Stock-Based Compensation | Compensation costs that have been included in our condensed consolidated statements of operations and comprehensive loss for all stock-based compensation arrangements is set forth below:
|  | Three months ended March 31, |
Stock-based compensation |  | 2025 |  |  | 2024 |
Cost of revenues |  | $ | 15 |  |  | $ | 45 |
Sales and marketing |  |  | 8 |  |  |  | 14 |
General and administrative |  |  | 67 |  |  |  | 556 |
Research and development |  |  | (4 | ) |  |  | 15 |
Total stock-based compensation |  | $ | 86 |  |  | $ | 630 |
Schedule of Restricted Stock Unit Activity | A summary of our restricted stock unit activity for the three months ended March 31, 2025 is set forth below:
|  | Shares |  |  | Weighted Average Grant Date Fair Value |
Outstanding as of December 31, 2024 |  |  | 38,420 |  |  | $ | 23.01 |
Granted |  |  | - |  |  |  | - |
Released |  |  | - |  |  |  | - |
Forfeited |  |  | (3,000 | ) |  |  | 14.00 |
Outstanding as of March 31, 2025 |  |  | 35,420 |  |  | $ | 23.77 |
Schedule of Stock Option Activity | A summary of our stock option activity under the 2018 Equity Incentive Plan (the “2018 Plan) and related information is as follows:
|  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (years) |  | Aggregate Intrinsic Value |
Outstanding as of December 31, 2024 |  |  | 2,500 |  |  | $ | 56.89 |  |  |  |  |  |
Granted |  |  | - |  |  |  | - |  |  |  |  |  |
Exercised |  |  | - |  |  |  | - |  |  |  |  |  |
Forfeited |  |  | (1,500 | ) |  | $ | 38.15 |  |  |  |  |  |
Outstanding as of March 31, 2025 |  |  | 1,000 |  |  | $ | 85.00 |  |  | 7.36 |  | $ | - |
Exercisable as of March 31, 2025 |  |  | 1,000 |  |  | $ | 85.00 |  |  | 7.36 |  | $ | - |
A summary of our option activity under our 2009 Equity Incentive Plan (the “2009 Plan”) and related information is as follows:
|  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (years) |  | Aggregate Intrinsic Value |
Outstanding as of December 31, 2024 |  |  | 1,190 |  |  | $ | 91.61 |  |  |  |  |  |
Granted |  |  | - |  |  |  | - |  |  |  |  |  |
Exercised |  |  | - |  |  |  | - |  |  |  |  |  |
Forfeited |  |  | - |  |  | 0 |  |  |  |  |  |
Outstanding as of March 31, 2025 |  |  | 1,190 |  |  | $ | 91.61 |  |  | 2.25 |  | $ | - |
Exercisable as of March 31, 2025 |  |  | 1,190 |  |  | $ | 91.61 |  |  | 2.25 |  | $ | - |

X
- Definition Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Paragraph a -Publisher SEC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3 + Details
Name: | srt_ScheduleOfCondensedIncomeStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration